Benzodiazepine withdrawal is often described as a short-term process that lasts a few weeks. For some people, however, symptoms don’t fully resolve after the acute phase. Instead, they persist for months or even longer. This experience is commonly referred to as protracted benzodiazepine withdrawal, or post-acute withdrawal syndrome (PAWS).1
Although not every clinician uses this term, the experience itself is documented in clinical literature and patient-reported studies.1 For those going through it, the symptoms can be confusing, frustrating, and at times overwhelming. Understanding protracted withdrawal can make a meaningful difference in how people cope and recover.
While acute withdrawal is typically driven by the body’s immediate response to the removal of benzodiazepines, protracted withdrawal is a longer-term neuroadaptation process. Rather than a single phase of withdrawal, it reflects ongoing adjustment in how the nervous system regulates excitability and stress response over time.1 This helps explain why symptoms may persist or fluctuate even after the drug has been discontinued.
Key Points
- Protracted withdrawal, also called PAWS, refers to symptoms that continue beyond the typical 4 to 8 week acute benzodiazepine withdrawal phase.
- An estimated 10 to 15% of long-term benzodiazepine users experience prolonged symptoms after the acute phase resolves.
- Symptoms can include anxiety, cognitive difficulties, sensory hypersensitivity, insomnia, and fatigue, and often fluctuate in a pattern of waves and windows.
- Most people notice meaningful improvement within 6 to 18 months, though recovery is gradual and nonlinear.
- Management focuses on supportive care, including CBT, sleep hygiene, moderate exercise, and peer support rather than any single cure.
- Seek professional help if symptoms significantly interfere with daily functioning, relationships, work, or safety.
What Is Protracted Benzodiazepine Withdrawal (PAWS)?
Protracted benzodiazepine withdrawal produces symptoms that continue beyond the typical acute phase, which usually lasts 4 to 8 weeks after reducing or stopping benzodiazepine use.1
During acute withdrawal, symptoms are often intense and may include anxiety, insomnia, tremors, and physical discomfort. In contrast, protracted withdrawal tends to involve ongoing, fluctuating symptoms that can persist for months or longer.1 It’s important to distinguish protracted withdrawal from:1
- Rebound symptoms, which are the temporary intensification of original symptoms after discontinuation
- Return of underlying conditions, such as pre-existing anxiety disorders
Protracted withdrawal differs since your symptoms may be new, prolonged, or atypical compared to prior baseline functioning, and may last from weeks to years.2
Clinical descriptions also note that symptom presentation is not always predictable and depends on dosage, taper speed, or how long you used the drug. Some individuals experience prolonged symptoms even after gradually tapering, while other people recover more quickly despite higher exposure, suggesting individual variability in nervous system recovery.1
How Common Is Protracted Withdrawal?
Not everyone who stops benzodiazepines will experience protracted withdrawal. However, research suggests that it occurs in a meaningful minority of long-term users. Estimates suggest that approximately 10 to 15% of long-term benzodiazepine users experience prolonged symptoms beyond the acute phase.1
Reported prevalence varies depending on study design, definitions, and whether data are drawn from clinical samples or patient-reported surveys, which can capture a wider range of experiences. This variation contributes to ongoing certainty in the literature about exact rates. Identified risk factors include:1,3
- Long-term benzodiazepine use
- Higher doses
- Rapid tapering or abrupt discontinuation
- Prior withdrawal attempts
- Polypharmacy
These factors generally increase your risk, but they don’t guarantee that you’ll develop PAWS.
Symptoms of Protracted Benzo Withdrawal
Protracted benzodiazepine withdrawal can affect multiple systems in the body, which is why symptoms often feel wide-ranging and difficult to pin down.1 They also tend to fluctuate over time, sometimes improving and then returning in waves.
In many cases, people report that these symptoms feel different from what they experienced before taking benzodiazepines.1 These symptoms are often grouped into several categories.
Psychological Symptoms
Many people experience ongoing emotional and mood-related symptoms during protracted withdrawal. These can persist even when external stressors are minimal. Emotional symptoms may feel amplified or disconnected from situational triggers. This can contribute to distress and confusion during recovery. Psychological symptoms of PAWS may include:1
- Anxiety
- Panic
- Irritability
- Mood instability
- Depersonalization
- Derealization
- Depression
Cognitive Symptoms
Cognitive effects are also common and can interfere with daily functioning, work, and concentration. These symptoms often involve executive functioning, including difficulty with attention regulation, working memory, and mental processing speed. Even routine tasks may take more effort or feel unfamiliar during prolonged periods of symptoms. Cognitive symptoms of PAWS may include:1
- Brain fog
- Difficulty concentrating
- Memory issues
Neurological and Sensory Symptoms
Some of the most distinctive symptoms involve the nervous system and sensory processing. These can feel unusual or unfamiliar. Some of the neurological and sensory symptoms associated with PAWS include:1
- Sensory hypersensitivity (light, sound, and touch)
- Tinnitus (ringing in the ears)
- Dizziness or balance issues
Physical Symptoms
Physical symptoms may be less intense than those experienced during acute withdrawal but can still be persistent and disruptive.1 Some of the physical symptoms associated with PAWS include:
- Insomnia
- Fatigue
- Muscle pain or tension
PAWS Symptom Fluctuation: Waves and Windows
One of the most commonly reported patterns in protracted benzodiazepine withdrawal is known as “waves and windows.”1 This describes the way symptoms tend to come and go, rather than follow a steady, predictable path.
Waves refer to periods when symptoms intensify, sometimes unexpectedly. Windows, on the other hand, are periods when symptoms ease, and a person may feel closer to normal functioning.1
Over time, many people notice that windows become longer and more frequent, while waves become shorter or less intense. Although waves can feel discouraging, this pattern is generally understood as a sign that the nervous system is gradually stabilizing.1
The presence of windows, even if brief or inconsistent, is often viewed in clinical descriptions and patient reports as evidence of ongoing recovery rather than deterioration. During wave periods, it can be helpful to focus on practical coping strategies, including reducing stimulation, prioritizing rest, maintaining consistent routines, and using grounding techniques for anxiety.
How Long Does Protracted Withdrawal Last?

The duration of protracted benzodiazepine withdrawal can vary significantly from person to person. There is no single timeline that applies to everyone, which can make the experience feel uncertain. That said, some general patterns have been observed.
Many people say that they notice a positive change within 6 to 18 months. A smaller number of people say they experience symptoms beyond that time range, but this appears to be less common.1
Recovery is typically gradual and not linear. Improvements may come in stages, with periods of progress followed by temporary setbacks. Setting realistic expectations can help reduce frustration. Rather than looking for a sudden resolution, it can be more helpful to track incremental improvements over time.1
Even when symptoms last longer, the intensity often decreases gradually rather than remaining constant, a key feature used to distinguish protracted withdrawal from static chronic conditions.
Managing Protracted Withdrawal
There is no single treatment that resolves protracted benzodiazepine withdrawal. Instead, management focuses on supporting the body and mind during recovery while addressing specific symptoms. Because protracted withdrawal affects multiple systems, management is typically best understood as supportive and multidisciplinary rather than curative.1
Therapy and Emotional Support
Cognitive behavioral therapy (CBT) can be particularly helpful for managing persistent anxiety, intrusive thoughts, and stress.4 CBT provides patients with practical tools that can help navigate difficult periods. CBT in this context is generally aimed at improving coping skills and reducing distress rather than directly altering the underlying withdrawal process.
Sleep Support
Insomnia is one of the most common and persistent symptoms. Consistent sleep hygiene practices, such as a regular schedule, limiting caffeine, and creating a calm nighttime routine, can support gradual improvement.1
Physical Health and Lifestyle
Regular, moderate exercise and balanced nutrition can help stabilize mood, improve sleep, and support overall recovery.1 While these changes may not eliminate symptoms immediately, they contribute to long-term resilience.
Peer Support and Community
Many people find reassurance in connecting with others who have had similar experiences.3 Organizations, such as the Benzodiazepine Information Coalition and peer communities like BenzoBuddies, provide shared knowledge and support.
Medication Considerations
In some cases, additional medications may be considered to help manage specific symptoms. This should always be done under medical supervision, as some medications can complicate recovery.1
Ongoing Care and Aftercare
Structured support can also play a role during longer recovery periods. Patience is central to managing protracted withdrawal. While progress may feel slow, gradual improvement is the most common outcome.1
When to Seek Additional Help
While many people can manage protracted withdrawal symptoms with time and support, you may need additional help in certain situations.1 Consider seeking professional support if:
- Symptoms significantly interfere with daily functioning
- Anxiety, depression, or distress feels unmanageable
- Sleep disruption becomes severe or persistent
- Relationships, work, or safety are affected
Clinical evaluation is also important to distinguish withdrawal-related symptoms from co-occurring or underlying conditions that may require separate treatment.1
In some cases, symptoms may overlap with or trigger other conditions, such as anxiety or depression. Professional support may include therapy, medical evaluation, or structured treatment programs. Reaching out for help is not a setback. It’s a step toward stabilization and recovery.
FAQs
In most cases, no. While symptoms can last for months or longer, the general pattern is one of gradual improvement. Long-term, permanent symptoms are not considered typical.
Current evidence does not support the idea that protracted withdrawal reflects permanent brain damage. Instead, symptoms are thought to result from temporary changes in the nervous system that gradually stabilize.
Only a qualified healthcare provider should make this decision with your input, while considering the potential risks and benefits. Whether medication could help depends on the individual situation. Some people benefit from targeted symptom management, while others prefer to avoid additional medications.
References
- Ashton, H.C. (2011). Benzodiazepines: How They Work and How to Withdraw. Retrieved April 25, 2026, from https://www.benzoinfo.com/wp-content/uploads/2022/07/Ashton-Manual.pdf
- U.S. Food and Drug Administration (2020). Benzodiazepine Drug Class: Drug Safety Communication. Retrieved April 25, 2026, from https://www.fda.gov/safety/medical-product-safety-information/benzodiazepine-drug-class-drug-safety-communication-boxed-warning-updated-improve-safe-use
- Huff, C., et al. (6 Feb 2023). Enduring neurological sequelae of benzodiazepine use: an internet survey. Therapeutic Advances in Psychopharmacology (13). Retrieved April 25, 2026, from https://pubmed.ncbi.nlm.nih.gov/36760692/
- Hofmann, S.G., et al. (1 Oct 2012). The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-Analyses. Cognitive Therapy and Research (36):5, 427-440. Retrieved April 25, 2026, from https://pubmed.ncbi.nlm.nih.gov/23459093/




































































































